Concepedia

Glen Dranoff

GD

Statistics

Publications

9

Citations

4K

H-Index

9

Active since

1993

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Johns Hopkins University

Harvard University Press

VA Boston Healthcare System

Glen Dranoff is an author at Dana-Farber Cancer Institute specializing in immunology, oncology, and cancer immunology.

Publications per year

1993–2014

9

Publications

9

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al. · Proceedings of the National Academy of Sciences · 1993 · 2.8K citations

, , +17

Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

J.W. Simons, Elizabeth M. Jaffee, C. Weber et al. · The Journal of Urology · 1998 · 414 citations

, , +13

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.

Joachim L. Schultze, S. Michalak, Mark J. Seamon et al. · Journal of Clinical Investigation · 1997 · 356 citations · Full text

, , +17

Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.

Ulrich Herrlinger, CM Kramm, Karen M. Johnston et al. · PubMed · 1998 · 110 citations

, , +14

Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.

Mikayla Mackey, Jason R. Gunn, P P Ting et al. · PubMed · 1997 · 107 citations

, , +17

1–5 of 9